Shifting to the long view: engagement of pregnant and postpartum women living with HIV in lifelong antiretroviral therapy services.
Tamsin Kate PhillipsLandon MyerPublished in: Expert review of anti-infective therapy (2019)
Introduction: The advent of policies promoting lifelong antiretroviral therapy (ART) for all pregnant and postpartum women living with HIV has shifted focus from short-term prevention of mother-to-child transmission (PMTCT) to lifelong engagement in ART services. However, disengagement from care threatens the long-term treatment and prevention benefits of lifelong ART. Areas covered: A framework for considering the unique aspects of ART for pregnant and postpartum women is presented along with a review of the literature on maternal engagement in care in sub-Saharan Africa and a discussion of potential interventions to sustain engagement in lifelong ART. Expert opinion: Engaging women and mothers in ART services for life is critical for maternal health, PMTCT, and prevention of sexual transmission. Evidence-based interventions exist to support engagement in care but most focus on periods of mother-to-child transmission risk. In the long term, life transitions and health-care transfers are inevitable. Thus, interventions that can reach beyond a single facility or provide a bridge between health services should be prioritized. Multicomponent interventions will also be essential to address the numerous intersecting barriers to sustained engagement in ART services.
Keyphrases
- antiretroviral therapy
- healthcare
- hiv infected
- mental health
- pregnancy outcomes
- human immunodeficiency virus
- social media
- hiv positive
- polycystic ovary syndrome
- hiv infected patients
- hiv aids
- affordable care act
- primary care
- pregnant women
- physical activity
- palliative care
- public health
- breast cancer risk
- cervical cancer screening
- quality improvement
- health information
- pain management
- birth weight
- risk assessment
- type diabetes
- health insurance
- clinical practice
- human health
- combination therapy
- hepatitis c virus
- climate change
- gestational age